Related Experiment Video
Updated: Jun 4, 2026

07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Robot-assisted partial nephrectomy: current status, techniques, and future directions
Paurush Babbar1, Ashok K Hemal
1Department of Urology and Institute of Regenerative Medicine, Robotics and Minimally Invasive Surgery, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1094, USA.
International Urology and Nephrology
|February 26, 2011
Summary
Robot-assisted partial nephrectomy (RAPN) offers a promising minimally invasive approach for small renal masses (SRMs), overcoming laparoscopic challenges. While short-term outcomes are comparable to open surgery, long-term results and cost-effectiveness require further investigation.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Small renal masses (SRMs) are increasingly detected incidentally.
- Renal preservation is recognized for its benefits.
- Open partial nephrectomy and laparoscopic partial nephrectomy (LPN) are established treatments for SRMs.
Purpose of the Study:
- To review the techniques and current status of robot-assisted partial nephrectomy (RAPN) for SRMs.
- To explore the advantages, disadvantages, and evolving techniques of RAPN.
- To analyze RAPN outcomes including ischemia time, blood loss, and oncological results.
Main Methods:
- Review of current literature on robot-assisted partial nephrectomy (RAPN).
- Analysis of RAPN outcomes compared to open and laparoscopic approaches.
- Discussion of surgical techniques, learning curve, and cost-effectiveness.
Main Results:
- Robot-assisted partial nephrectomy (RAPN) overcomes technical challenges of LPN, facilitating minimally invasive surgery for SRMs.
- Short-term oncological outcomes of RAPN are comparable to open surgery, with improved morbidity compared to LPN.
- Key parameters like warm ischemia time, blood loss, and hospital stay are evaluated.
Conclusions:
- Robot-assisted partial nephrectomy (RAPN) is a promising procedure for nephron-sparing surgery in SRMs.
- Further research on long-term oncological outcomes and cost reduction is needed.
- Advancements in technology and training will increase RAPN adoption and patient benefit.

